Thank you for posing such a leading-edge question. I surmise its answer may have a rather different din a few years from now. However, to date, I am not using DOTATATE PET for meningioma. This is due partly to habit, availability, insurance constraints, and the specific clinical circumstances of the...

Very nice review by Dr. @C. Leland Rogers. In addition to his nice review, I also like a new paper from Bashir et al., PMID 33526423 published in Clinical Cancer Research this year where the authors performed dotatatePET for 37 meningioma cases after GTR. They showed that 23/37 cases had PET avid di...

This is a very nice synopsis of the available data. We have been using the Ga-68 DOTATATE PET for similar situations and have just over 50 patients now. In our experience, it is extremely useful for target delineation for falx/skull base tumors with osseous involvement, either GTR or STR. I have fou...